article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 166
article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Unfortunately, this change in policy has been promised for years and never actually materialized.”.

DEA 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Thoughts on THCA, Interstate Sales…. and Oregon

Canna Law Blog

Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.

DEA 82
article thumbnail

Green Light Law Group: DEA ANNOUNCEMENT MARKS END OF ERA

Cannabis Law Report

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45
article thumbnail

The Key Differences Between CBD and THC You Need to Know

United Patients Group

Hemp-derived CBD must have a THC concentration of 0.3 CBD is available in many forms, including gels, gummies , oils, supplements, concentrates, and more. However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification. percent or less to be legally sold.

THC 117
article thumbnail

FDA Suggests Congress Holds the Key to Legalizing CBD-Infused Foods

Canna Law Blog

As we previously discussed , thus far, the FDA has only adopted informal, non-binding guidelines as its primary method of policy making for CBD as they afford the agency more flexibility. I think the prevailing view is that the plain language of the statute [the Farm Bill] intended for that, but I’m not sure that DEA has done that yet.

Food 81
article thumbnail

Studies Dispel the Myth That Cannabis is a Performance Enhancing Drug

Veriheal

Office of National Drug Control Policy defined that the medal “seemed to directly undercut our messages to young people that drug use undermines a child’s opportunities for success.” Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research. Soon after Rebagliati’s case, a paper released by the U.S.

DEA 98